First Trust Nasdaq Pharmaceuticals ETF
FTXH
FTXH
19 hedge funds and large institutions have $8.13M invested in First Trust Nasdaq Pharmaceuticals ETF in 2024 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 2 increasing their positions, 7 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
less capital invested
Capital invested by funds: $ → $
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
71% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 7
Holders
19
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$1.03M | |
| 2 | +$257K | |
| 3 | +$249K | |
| 4 |
VCM
Vivaldi Capital Management
Chicago,
Illinois
|
+$229K |
| 5 |
CA
Continuum Advisory
Eagle,
Idaho
|
+$17.5K |
Top Sellers
| 1 | -$615K | |
| 2 | -$500K | |
| 3 | -$494K | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$384K |
| 5 |
OWA
Outlook Wealth Advisors
Shenandoah,
Texas
|
-$229K |